409 related articles for article (PubMed ID: 24212628)
1. Protein kinase C: an attractive target for cancer therapy.
Marengo B; De Ciucis C; Ricciarelli R; Pronzato MA; Marinari UM; Domenicotti C
Cancers (Basel); 2011 Feb; 3(1):531-67. PubMed ID: 24212628
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.
Hanauske AR; Sundell K; Lahn M
Curr Pharm Des; 2004; 10(16):1923-36. PubMed ID: 15180529
[TBL] [Abstract][Full Text] [Related]
3. Potentials of PKC in Cancer Progression and Anticancer Drug Development.
Deka SJ; Trivedi V
Curr Drug Discov Technol; 2019; 16(2):135-147. PubMed ID: 29468974
[TBL] [Abstract][Full Text] [Related]
4. HSP27-Mediated Extracellular and Intracellular Signaling Pathways Synergistically Confer Chemoresistance in Squamous Cell Carcinoma of Tongue.
Zheng G; Zhang Z; Liu H; Xiong Y; Luo L; Jia X; Peng C; Zhang Q; Li N; Gu Y; Lu M; Song Y; Pan H; Liu J; Liu W; He Z
Clin Cancer Res; 2018 Mar; 24(5):1163-1175. PubMed ID: 29246940
[No Abstract] [Full Text] [Related]
5. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
[TBL] [Abstract][Full Text] [Related]
7. Protein Kinase C-ζ stimulates colorectal cancer cell carcinogenesis via PKC-ζ/Rac1/Pak1/β-Catenin signaling cascade.
Islam SMA; Patel R; Acevedo-Duncan M
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):650-664. PubMed ID: 29408512
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
9. Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis.
Barrett CM; Lewis FL; Roaten JB; Sweatman TW; Israel M; Cleveland JL; Lothstein L
Mol Cancer Ther; 2002 May; 1(7):469-81. PubMed ID: 12479265
[TBL] [Abstract][Full Text] [Related]
10. PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation.
Jiffar T; Kurinna S; Suck G; Carlson-Bremer D; Ricciardi MR; Konopleva M; Andreeff M; Ruvolo PP
Leukemia; 2004 Mar; 18(3):505-12. PubMed ID: 14737078
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
Isakov N
Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C: a worthwhile target for anticancer drugs?
Caponigro F; French RC; Kaye SB
Anticancer Drugs; 1997 Jan; 8(1):26-33. PubMed ID: 9147607
[TBL] [Abstract][Full Text] [Related]
13. Activation of conventional PKC isoforms increases expression of the pro-apoptotic protein Bad and TRAIL receptors.
Farrow B; Thomas RP; Wang XF; Evers BM
Int J Gastrointest Cancer; 2002; 32(2-3):63-72. PubMed ID: 12794242
[TBL] [Abstract][Full Text] [Related]
14. Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha.
Garcia-Bermejo ML; Leskow FC; Fujii T; Wang Q; Blumberg PM; Ohba M; Kuroki T; Han KC; Lee J; Marquez VE; Kazanietz MG
J Biol Chem; 2002 Jan; 277(1):645-55. PubMed ID: 11584014
[TBL] [Abstract][Full Text] [Related]
15. Signaling cascades in radiation-induced apoptosis: roles of protein kinase C in the apoptosis regulation.
Nakajima T
Med Sci Monit; 2006 Oct; 12(10):RA220-4. PubMed ID: 17006414
[TBL] [Abstract][Full Text] [Related]
16. The Enigmatic Protein Kinase C-eta.
Basu A
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781807
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
18. POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway.
Weng T; Koh CG
Cell Death Dis; 2017 Sep; 8(9):e3051. PubMed ID: 28906490
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells.
Gonzalez-Guerrico AM; Meshki J; Xiao L; Benavides F; Conti CJ; Kazanietz MG
J Biochem Mol Biol; 2005 Nov; 38(6):639-45. PubMed ID: 16336777
[TBL] [Abstract][Full Text] [Related]
20. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
